🕤  09:30 - 11:00 

Session 10  -  Speakers session  

Theme: Engineering the Future of Brain Health  

 Chair   Gregory Roumeliotis, Associate Partner, BioInnovation Greece 

 Speakers   

• Zois Syrgiannis, CEO,  NanoNeurosciences Inc., USA

Title: Engineering Healing: How Nanoarchitectures Target Mitochondria Powering Regeneration

• Charalampos Tzoulis, Professor of Neurology & Neurogenetics, Director, K.G Jebsen Center for Parkinson's disease, University of Bergen, Norway

Title: Chasing the cure for Parkinson’s: translating science into clinical impact

• Dimitri Dimitriou, Executive Chairman, CEO, Neurentis plc, UK

Title: How Small Biotechs Are Powering Big Pharma

• Zoe Kourtzi, Professor, University of Cambridge, UK

Title: AI for better brain and mental health: from cloud to clinic

🕦  11:30 - 13:00      

Session 11  -  Speakers session 

Theme: Reprogramming Immunity: The Next Wave of Therapeutic Innovation  

 Chair   Evangelos Andreakos, Director, Center for Clinical, Experimental Surgery and Translational Research, BRFAA

 Speakers   

• Andreas Katopodis, CEO and co-founder ANAVEON AG, Switzerland

Title: Cytokine therapies for cancer and immunological diseases 

• Elias Papatheodorou, CEO, HepaRegenix, Germany

Title: Regeneration: An unconquered health frontier

• Dimitris Skokos, VP, Cancer Immunology at Regeneron Pharmaceuticals, Inc. , USA

Title: Unlocking the Immune System: Advanced Combination Strategies for Cancer Immunotherapy

• Kleanthis Xanthopoulos, Chairman & CEO at Shoreline Biosciences, Inc.  USA

Title: Can Cell Therapy Break Out of Hematology?

🕑  14:00 - 14:30  

Session 12 -  Keynote Talk  

 Chair   TBD

 Speaker   TBD

Title: TBD

🕝  14:30 - 15:30  

Session 13  -  Round Table  

Theme: The MedTech Disruptors: From Concept to Cure or Biotech Frontiers  

 Chair   Giorgos Papatheodoridis, Professor in Medicine, NKUA,  President of the Hellenic Transplant Organization 

 Panelists   

• Maria Limberis, Consultant & Editor, Human Gene Therapy, Mary Ann Liebert, Inc. , USA

• Georgios Voidonikolas, Transplant Surgeon, Jim and Eleanor Randall Department of Surgery, Cedars-Sinai, USA

• Dimitris Nikas, Country Managing Director at Medtronic, Greece

• Alexandros Spyridonidis, Professor of Hematology, Director of BMT Unit and Institute of Cell Therapy, Univ of Patras, Greece

• Adrianos Golemis, ESA Lead Flight Surgeon (MEDES), European Astronaut Centre, Cologne, Germany

🕓  16:00 - 16:30 

Session 14  -  Fireside Chat  

Theme: The Science of Returns: Innovation Through the Investor’s Lens  

 Moderator  Lina Nikolopoulou, Managing Director, MINDVIEW Strategy & Research, Greece

 Featured Guest  Haris Lambropoulos, President at Hellenic Development Bank of Investments S.A (HDBI), Greece

🕕 16:30 - 16:45 

Session 15  -  Spotlight Talk

 Chair   Roula Bachtalia, Head of Venture Banking · Eurobank, Greece

 Speaker  Yannis Tsakiris, Vice President of the European Investment Bank, Luxembourg

Title: Innovation and Competitiveness: The Role of the EIB.

🕟 16:45 - 17:45 

Session 16  -  Round Table  

Theme: EquiFund and Beyond: Laying the Foundation for Greece’s Biotech Renaissance  

 Chair   Roula Bachtalia, Head of Venture Banking · Eurobank, Greece

 Panelists   

• Ioanna Mylonaki, Partner, Untethered Ventures, Greece

• Alexandra Tolia, Managing Partner, Rhea BioVentures, Greece

• Harietta Eleftherochorinou, Vice President, IQVIA Innovation Hub, Greece

• George Passaris, Director & Senior Regional Representative for Greece & Cyprus,  European Investment Fund (EIF), Greece

• Spyros Kintzios, Director Corporate Development & Strategy, Uni-Pharma, Greece

🕡  18:15 - 19:15 

Session 17  -  Round Table  

Theme: Fueling the Future: Capital Strategies for Biotech Growth  

 Chair   Athanassios Niforos, Founder, Acacia Investor Relations, Greece

 Panelists   

• Yianos Kontopoulos, CEO, Athens Exchange Group (ATHEXGROUP), Greece 

• Maggie Athanassiadi, Director οf Technology, Innovation & Digital Transformation, SEV, Greece

• Antigoni Lymperopoulou, CEO, HDBI S.A, Greece

• Alex Tzoukas, Managing Partner and Co-Founder, Kos Biotechnology Partners, Greece

• Spyros Arsenis, Head of NBG Innovation Unit , National Bank of Greece, Greece